An interventional study of telemonitoring in Hypertension, sponsored by International Society for Vascular Health. Status unknown at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-08-09.
Sponsored by International Society for Vascular Health · Not applicable, Interventional, and Other
The present prospective study aims to assess the efficacy of using the telehealth solution "Hypertension Monitor" in patients with hypertension by comparison to the standard care.
Although, meta-analysis confirms that BP telemonitoring may represent a useful tool to improve hypertension management, the strength of the provided evidence is limited. Therefore, future well-designed, large-sample, prospective, controlled trials are mandatory to understand the benefit of BP telemonitoring.
Recently, a specific telehealth solution for hypertension management has been developed in France (Hypertension Monitor - e-CoreLab®).
The present prospective study aims to assess the efficacy of using the telehealth solution "Hypertension Monitor" in patients with hypertension by comparison to the standard care.
The primary objective: To evaluate whether a home telehealth system can improve BP control and other risk factors in hypertensive individuals, as compared to the standard care.
Exclusion Criteria:
This group is the usual standard treatment group
This group will followed up with telemonitoring
Other: telemonitoring
the follow-up of the patient will be performed with Telemonitoring
Systolic Blood Pressure (measured in clinic)
Systolic blood pressure will be measured in clinic according to the guidelines of the European Society of Hypertension (ESH).
Time frame: Primary objective after 3 month
Timing to reach the blood pressure target
how long we need to reach the Blood pressure normalization
Time frame: Evaluation performed at Month1 and Month 3
Plan to share: Yes — the essential documents and the study results will be shared with all the investigators.
Supporting information: Study protocol, Sap, Icf, Csr
No publications or documents are linked to this record.
This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
International Society for Vascular Health